University
Neurology
Piero Antuono works in the field of Neurology. He went to medical school at Medical College of Wisconsin Affiliated Hospitals. He received awards:"Eureka Award", "Researcher of the Year", "Physicians Award", "A.R.A.D. Award", "Certificate of Appreciation", "Induction in the Men of Achievement Section", "Henrietta McNary Award", "Community Connection Award", "Teacher of the Year Award", "Certificate of Recognition", "The Governor of Wisconsin Certificate of Commendation for Alzheimers Disease", "Certificate of Merit", "Combined Federal Campaign, Certificate of Merit" and "Best in Milwaukee Under 40". Doctor Piero Antuono, MD is a published doctor and has 64 publications published. The lastest was: 'Cytochrome oxidase in Alzheimer''s disease: biochemical, histochemical, and immunohistochemical analyses of the visual and other systems.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Amygdala network dysfunction in late-life depression phenotypes: Relationships with symptom dimensions.
- Aberrant functional connectivity in Papez circuit correlates with memory performance in cognitively intact middle-aged APOE4 carriers.
- Effects of the coexistence of late-life depression and mild cognitive impairment on white matter microstructure.
- Modulation of human longevity by SIRT3 single nucleotide polymorphisms in the prospective study "Treviso Longeva (TRELONG)"
- Functional network endophenotypes unravel the effects of apolipoprotein e epsilon 4 in middle-aged adults.
- Semantic memory functional MRI and cognitive function after exercise intervention in mild cognitive impairment.
- A method to determine the necessity for global signal regression in resting-state fMRI studies.
- Body Mass Index, Cognition, Disability, APOE Genotype, and Mortality: The "Treviso Longeva" Study.
- Correlation of computed tomography and postmortem findings of a diffuse astrocytoma: a case report.
- Alzheimer Disease: quantitative analysis of I-123-iodoamphetamine SPECT brain imaging.
- Methylazoxymethanol acetate cortical hypoplasia alters the pattern of stimulation-induced behavior in neonatal rats.
- The development of daytime rearing behavior in methylazoxymethanol-treated rats: methodological considerations.
- Nicotinic acetylcholine binding sites in Alzheimer''s Disease.
- Late-life depression, mild cognitive impairment and hippocampal functional network architecture.
- Regional heterogeneity of choline acetyltransferase activity in primate neocortex.
- Correlation of neuronal cell body size in motor cortex and hippocampus with body height, body weight, and axonal length.
- A treatment and withdrawal trial of besipirdine in Alzheimer Disease.
- Leukocyte hexokinase activity in aging and Alzheimer Disease.
- Effectiveness and safety of velnacrine for the treatment of Alzheimer's Disease. A double-blind, placebo-controlled study. Mentane Study Group.
- Decreased glutamate + glutamine in Alzheimer's Disease detected in vivo with (1)H-MRS at 0.5 T.
- Alzheimer Disease: evaluation of a functional MR imaging index as a marker.
- Task-modulation of functional synchrony between spontaneous low-frequency oscillations in the human brain detected by fMRI.
- Proton magnetic resonance spectroscopy of the hippocampus in patients with mild cognitive impairment: a pilot study.
- Perfusion fMRI detects deficits in regional CBF during memory-encoding tasks in MCI subjects.
- Neural correlates of the interactive relationship between memory deficits and depressive symptoms in nondemented elderly: resting fMRI study.
- Recovery of hippocampal network connectivity correlates with cognitive improvement in mild Alzheimer's Disease patients treated with donepezil assessed by resting-stat...
- Auto-Contractive Maps: an artificial adaptive system for data mining. An application to Alzheimer Disease.
- Semantic memory activation in amnestic mild cognitive impairment.
- Semantic memory activation in individuals at risk for developing Alzheimer Disease.
- Factors related to disability: evidence from the "Treviso Longeva (TRELONG) study".
- Codon 129 polymorphism of prion protein gene in sporadic Alzheimer''s Disease.
- Physical activity, socialization and reading in the elderly over the age of seventy: what is the relation with cognitive decline? Evidence from "The Treviso Longeva (T...
- A reason to hope: linking Dementia research, care and services in the 21st century.
- Alzheimer Disease risk associated with APOE4 is modified by STH gene polymorphism.
- Genotypes and haplotypes in the IL-1 gene cluster: analysis of two genetically and diagnostically distinct groups of Alzheimer patients.
- Diagnostic criteria for Dementia in clinical trials. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
- Cytochrome oxidase in Alzheimer''s Disease: biochemical, histochemical, and immunohistochemical analyses of the visual and other systems.
- The burden of Dementia. A medical and research perspective.
- Potential clinical use of an adrenergic/cholinergic agent (HP 128) in the treatment of Alzheimer's Disease.
- Psychopharmacological prospectives in the treatment of Dementia.
- Study of epidemiological and etiological factors of amyotrophic lateral sclerosis in the province of Florence, Italy.
- A possible mechanism for cholesteryl ester formation during demyelination: lecithin:cholesterol acyltransferase (LCAT) activity in rat brain.
- Balint''s syndrome and transient global amnesia as a result of carbon monoxide (CO) poisoning.
- Choline acetyltransferase and acetylcholinesterase abnormalities in senile Dementia: importance of biochemical measurements in human post-mortem brain specimens.
- Progressive peroneal muscular atrophy (Charcot-Marie-Tooth Disease) associated with beta-thalassemia trait and glucose-6-phosphate dehydrogenase (G-6-PD) deficiency. A...
- Medial temporal lobe activity for recognition of recent and remote famous names: an event-related fMRI study.
- Artificial neural networks and artificial organisms can predict Alzheimer pathology in individual patients only on the basis of cognitive and functional status.
- Response to The UCSD Statin Study: a randomized controlled trial assessing the impact of statins on selected noncardiac outcomes".
- Age-related functional recruitment for famous name recognition: an event-related fMRI study.
- Methylenetetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms in two genetically and diagnostically distinct cohort of Alzheimer patients.
- Alzheimer''s Disease and vascular dementia in developing countries: prevalence, management, and risk factors.
- Survival in Alzheimer''s Disease is shorter in women carrying heterozygosity at codon 129 of the PRNP gene and no APOE epsilon 4 allele.
- The phase shift index for marking functional asynchrony in Alzheimer's Disease patients using fMRI.
- Temporally graded activation of neocortical regions in response to memories of different ages.
- Neuropathological findings processed by artificial neural networks (ANNs) can perfectly distinguish Alzheimer''s patients from controls in the Nun Study.
- Prediction of cognitive decline in healthy older adults using fMRI.
- Interactive effects of physical activity and APOE-?4 on BOLD semantic memory activation in healthy elders.
- Common neural systems associated with the recognition of famous faces and names: an event-related fMRI study.
- Ceruloplasmin (2-D PAGE) Pattern and Copper Content in Serum and Brain of Alzheimer Disease Patients.
- Semantic knowledge for famous names in mild cognitive impairment.
- Insulin-like growth factor 1 receptor polymorphism rs2229765 and circulating interleukin-6 level affect male longevity in a population-based prospective study (Treviso...
- Classification of Alzheimer Disease, mild cognitive impairment, and normal cognitive status with large-scale network analysis based on resting-state functional MR imag...
- Does physical activity influence semantic memory activation in amnestic mild cognitive impairment?
Schools
Universita Degli Studi Di Firenze Facolta Di Medicina E Chirurgia
University Firenze
Med College Of Wisconsin
Johns Hopkins University
Procedures Preformed
- Investigational Medication for Memory Loss
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Cerebrovascular Disease
- Dementia
- View All
Doctors Specialties
Accepted Insurances
Awards
- Eureka Award
- Researcher of the Year
- Physician’s Award
- A.R.A.D. Award
- Certificate of Appreciation
- Induction in the “Men of Achievement†Section
- Henrietta McNary Award
- Community Connection Award
- Teacher of the Year Award
- Certificate of Recognition
- The Governor of Wisconsin Certificate of Commendation for Alzheimer’s Disease
- Certificate of Merit
- Combined Federal Campaign, Certificate of Merit
- Best in Milwaukee Under 40
Education
-
Johns Hopkins University
-
Medical College of Wisconsin Affiliated Hospitals
-
University of Florence Faculty of Medicine
Hospital
-
Children's Hospital of Wisconsin
-
Froedtert Memorial Lutheran Hospital
Drug Facts
| NPI NUMBER |
|
1750332268 |
| NPPES Provider LastName |
|
ANTUONO |
| NPPES Provider FirstName |
|
PIERO |
| NPPES Provider ZIPCode |
|
532263522 |
| NPPES Provider State |
|
WI |
| Specialty Description |
|
Neurology |
| Total Claim Count |
|
873.0 |
| Distinct Opioid Count |
|
0.0 |
| Opioid Claim Count |
|
0.0 |
| Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1750332268 |
| Last Name Of The Provider |
ANTUONO |
| First Name Of The Provider |
PIERO |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.
